pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Vera Therapeutics, Inc. ($VERA) · news · pharmadog
← back to Vera Therapeutics, Inc.
News mentioning $VERA
47
stories
Jul 8, 26
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
Jul 8, 26
STAT+: Europe will accelerate its review of RevMed’s drug
stat
Jul 8, 26
STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics
stat
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 8, 26
Another big premium hike on the horizon
stat
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
Jul 7, 26
Vera's IgAN approval kicks off competition with Otsuka
endpoints
Jul 7, 26
STAT+: FDA approves Vera Therapeutics kidney disease treatment
stat
Jul 7, 26
STAT+: Compass says depression drug has long-lasting benefits
stat
Jul 7, 26
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
stat
Jul 7, 26
Vera Therapeutics wins FDA nod for closely watched kidney disease drug
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 4, 26
Otsuka showcases kidney drug data; Pfizer cuts an AI deal
biopharma dive
Jun 2, 26
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
stat
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 12, 26
Second Clinical Scenario - Progressive Disease Despite Hematocrit Control
onclive
Apr 27, 26
Lilly to buy startup Ajax in bid for a better JAK drug
biopharma dive
← prev
page 2 of 2
next →
